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a b s t r a c t
The cysteine (Cys) proteome is a major component of the adaptive interface between the genome and
the exposome. The thiol moiety of Cys undergoes a range of biologic modiﬁcations enabling biological
switching of structure and reactivity. These biological modiﬁcations include sulfenylation and disulﬁde
formation, formation of higher oxidation states, S-nitrosylation, persulﬁdation, metalation, and other
modiﬁcations. Extensive knowledge about these systems and their compartmentalization now provides
a foundation to develop advanced integrative models of Cys proteome regulation. In particular, detailed
understanding of redox signaling pathways and sensing networks is becoming available to allow the
discrimination of network structures. This research focuses attention on the need for atlases of Cys
modiﬁcations to develop systems biology models. Such atlases will be especially useful for integrative
studies linking the Cys proteome to imaging and other omics platforms, providing a basis for improved
redox-based therapeutics. Thus, a framework is emerging to place the Cys proteome as a complement to
the quantitative proteome in the omics continuum connecting the genome to the exposome.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Introduction
The sulfur atom of cysteine (Cys) provides a considerable range
of chemical reactivity and structural ﬂexibility in the proteome.
The presence of conserved Cys in motifs of proteins found in
essentially all life forms indicates that these chemical character-
istics were harnessed in early evolution to support enzyme
catalysis, transcriptional regulation, protein folding, and three-
dimensional structure. A remarkable range of biologic functions is
supported by Cys because sulfur is stable in multiple coordinate
covalent bonds with the major atoms of living organisms (C, H, O,
N, P), forms stable coordinate complexes with transition metal
ions (Zn, Fe, Cu), and is stable at a range of oxidation states (–SH, –
SS–, –SO21, –SO31). Additionally, Cys thiols differentially undergo
reversible ionization to the negatively charged thiolate form over
the physiologic range of pH to ﬂexibly optimize the functions of
speciﬁc peptidyl Cys.
The human genome encodes about 214,000 Cys. Cys is widely
distributed among proteins, with most expressing at least one and
many having multiple coordinated Cys and Cys-rich domains. The
reactivity and diverse functions of Cys are mirrored by a spectrum
of susceptibilities and dysfunctions of their respective proteins,
resulting in central roles of the Cys proteome in development,
signal transduction, biologic defenses, aging, and disease. Con-
siderable knowledge has accumulated for the symptoms and
etiology of major human diseases, such as cardiovascular disease,
Alzheimer disease, lung disease, metabolic syndrome, eye disease,
and diseases of other organ systems. These often share related
oxidative phenotypes and mechanisms, and progress in redox
systems biology is beginning to provide an understanding of the
integration of the underlying redox systems.
Early photosynthetic organisms transformed the earth by ﬁxing
the carbon atom of CO2 into hydrocarbons and releasing bound
atomic oxygen as gaseous molecular O2. This changed the atmo-
sphere from o1% to about 21% O2 and had a profound effect on
life forms by creating a diversity of external environments with
different oxidative conditions. Contemporary redox proteomic
systems have evolved as a result of the selective pressures of an
oxygen environment and aerobic respiration, with extant genomes
having selectively advantageous redox proteomic structures that
protect the genome and ensure its replication despite environ-
mental, organismal, and developmental variation in oxidative and
reductive challenges. Although oxidative pressure inﬂuences mul-
tiple critical loci of the redox proteome, such as methionine (Met)
and selenocysteine (Sec), the Cys proteome is central within this
spectrum of biological plasticity and is the focus of this review.
The Cys proteome (Fig. 1) serves as a central adaptive interface
between the functional genome and the external environment of
an organism [1]. The external environment is a critical determi-
nant of individual survival; in human health, this is now discussed
in terms of an individual's “exposome” [2]. The exposome is
deﬁned as the cumulative measure of environmental inﬂuences
and associated biological responses throughout the life span,
including exposures from the environment, diet, behavior, and
endogenous processes [3]. In addition to utility in contemporary
environmental health research [3,4], this provides a useful way to
think about the evolution of complex multicellular organisms as
the content of O2 increased in the atmosphere. Speciﬁcally, the
redox sensing and signaling mechanisms supporting responses to
challenge also provided sensing and signaling systems for tem-
poral and spatial execution of differentiation and development in
multicellular organisms.
In the present review of the Cys proteome, we start with a
summary of lessons learned from study of the redox proteome,
that portion of reversible and irreversible covalent modiﬁcations
that link redox metabolism to biologic structure and function [1].
We follow this with a more speciﬁc consideration of the chemistry
of sulfur and the spectrum of oxidative reactions that deﬁnes Cys
proteomic functions. In a third section, we address the redox
regulation systems, especially focusing on major reducing systems
that balance the oxidative reactions and support a rapidly evolving
understanding of the spatiotemporal nature of redox regulation. In
this, we provide speciﬁc examples illustrating the organizational
structure of stable, kinetically controlled functional redox net-
works and summarize other modiﬁcations such as S-nitrosylation
and persulﬁdation. Finally, we discuss the Cys proteome within the
context of integrated omics approaches, highlighting the ongoing
need for development of quantitative redox biology models.
Lessons from the redox proteome
Central dogma
Cys is incorporated into protein as the thiol (RSH) form, with
apparently no exception. Thiols are oxidized to sulfenic acids
(RSO) intermediate to formation of disulﬁdes (RSSR) and higher
oxidation states (e.g., RSO2). Thiols and disulﬁdes also undergo
exchange reactions in which the thiol reacts to form a new
disulﬁde and liberates a different thiol (RSH þ R1SSR12 RSSR1
þ R1SH) [5]. Disulﬁde is a common posttranslational modiﬁcation
for three-dimensional structure, as a component of multistep
vectorial processing and transport, as a switching mechanism in
regulation or signaling, and as a consequence of oxidative stress.
Research with redox Western- and mass spectrometry-based
redox proteomics methods shows that partial oxidation is com-
mon for Cys residues throughout the proteome of mammalian
systems [6–10]. This contradicts earlier interpretations that Cys
thiol oxidation represents only an artifact of extraction [11] and
supports the hypothesis that signiﬁcant speciation of different
peptidyl Cys in basal oxidation, organization, and function occurs
within the Cys proteome.
Discussions of procedures and pitfalls in measurements of
thiols and thiol/disulﬁde have been reviewed [12–14]. Measure-
ments involving extraction and chemical modiﬁcation reﬂect the
efﬁciency of alkylation relative to oxidation in trapping the thiol
form (see Hansen and Winther [13] for detailed discussion).
Importantly, processing must be rapid under various conditions
to minimize both oxidative and reductive artifacts. Artifacts are
more likely in experimental studies with added oxidants, metal
ions, or electrophiles, especially if these are not removed before
processing biologic materials for thiol analysis. Extraction at 0 1C
slows reaction rates about 10-fold relative to 37 1C, and higher O2
in air-equilibrated solution increases rates about 5-fold that of
tissues in vivo in mammals. Thus, in the absence of added oxidants
and metals, oxidation of Cys during assay occurs at relatively slow
rates, similar to the ongoing autoxidation rates in vivo. High
concentrations of thiol-reactive chemicals can be readily achieved
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under most experimental conditions to minimize signiﬁcant
artifact [13]. An alternate reductive artifact can also occur with
addition of thiol-trapping reagents under conditions where
NADPH-dependent reduction continues.
Discussion of the redox activities of the Cys proteome requires
care in consideration of assumptions upon which interpretations are
based. For instance, redox potential refers to equilibrium conditions,
which can be approximated experimentally in dilute solution with
sufﬁcient equilibration time. However, total protein concentration in
biological systems is very high, many proteins are continuously
undergoing reversible interaction with other proteins, and many
processes are kinetically limited and displaced from equil-
ibrium. Local pH and metal ion concentrations may not be uniform,
and dynamic processes of phosphorylation/dephosphorylation, acet-
ylation/deacetylation, methylation/demethylation, reversible metal
ion binding, etc., may have an impact on in vivo properties. Most
of the time, data and analytical methods are insufﬁcient to fully
evaluate these possibilities. Furthermore, site-directed mutagenesis
studies to test the function of a Cys can be misleading if experimental
conditions do not replicate conditions under which the Cys inﬂu-
ences function. Such issues represent challenges for the future to
improve integrated redox biology models.
Protein thiols exist in a dynamic steady state
Targeted redox analyses of thioredoxin-1 (Trx1), thioredoxin
reductase-1, peroxiredoxin-1, mitochondrial Trx2, thioredoxin
reductase-2, peroxiredoxin-3, NF-κB (p50), redox factor-1, protein
disulﬁde isomerase, and other proteins (for summary, see [15,16])
show partial oxidation in cell culture under control conditions.
Studies of glutathionylation also reveal modiﬁed residues under
basal conditions, including Cys374 of actin in A431 cells [17] (more
discussion of Cys modiﬁcation below). However, these targeted
studies mostly involve proteins that are regulatory or signaling in
nature, leaving open the possibility that steady-state oxidation is
an uncommon event. An important breakthrough during the past
decade is derived from mass spectrometry-based proteomic
methods, which provide much greater coverage of oxidation of
the Cys proteome.
Sethuraman et al. [18] showed that isotope-coded afﬁnity tag
(ICAT) reagents [19] could be used to measure oxidation of
individual Cys-containing peptides, speciﬁcally comparing differ-
ences between control and H2O2-treated samples. The design in
this study did not permit evaluation of steady-state oxidation
without oxidant. Related methods used by Le Moan et al. [20],
Leichert et al. [21] and Go et al. [22,23] allow determination of the
percentage reduction of Cys under control as well as experimen-
tally treated conditions. For instance, proteins can be rapidly
extracted, treated with a heavy stable isotopic ICAT reagent,
treated with reductant, and ﬁnally treated with a light stable
isotopic ICAT reagent. With liquid chromatography–mass spectro-
metry/mass spectrometry (LC–MS/MS), this allows measurement
of the percentage oxidation of speciﬁc residues in peptide
sequences. Importantly, Le Moan et al. [20] showed that in yeast,
Cys in many proteins are partially oxidized under control condi-
tions. Leichert et al. [21] obtained similar results in studies of
Escherichia coli, and Go et al. found steady-state oxidation of
proteins in mouse aortic endothelial cells [22], HT29 colon
carcinoma cells [6], lung ﬁbroblasts [8], mouse liver [24], and liver
mitochondria [24].
More sensitive mass spectrometers and newer peptide tagging
methods are becoming available to further enhance sensitivity and
Fig. 1. The Cys proteome exists as an adaptive interface between the exposome and the functional genome. Research on integrated omics has emphasized the role of the
metabolome and the proteome as intermediates between environmental exposures and the genome, epigenome, and transcriptome. The Cys proteome has a more direct role
to support sensing and signaling of nutritional and environmental conditions and also to provide an array of reactive nucleophiles to neutralize toxic electrophilic chemicals.
Thus, the Cys proteome is an important functional component of the translated proteome, directly interacting with the metabolome to utilize environmental resources and
defend against environmental threats.
Y.-M. Go et al. / Free Radical Biology and Medicine 84 (2015) 227–245 229
coverage of the Cys proteome [6], and efforts to identify oxida-
tively sensitive Cys, the collective “sulfenylome” of protein Cys that
forms RSO in response to multiple stimuli, have yielded increas-
ingly promising results [25,26]. Although there remains a need for
caution until more independent analyses and conﬁrmations are
available, the mass spectrometry-based methods are enhancing
the ability to characterize both stable and transient, partially
oxidized Cys residues within the mammalian Cys proteome.
Knowledge of the functions of the redox-sensitive Cys residues
is of critical importance. The peptides detected are from relatively
abundant proteins and ionize well with available instrumentation.
This leaves open the possibility that the Cys residues measured by
LC–MS/MS are nonfunctional or function in a nonspeciﬁc way to
protect critical sites from thiol-reactive chemicals [27]. Three types
of evidence suggest that many have more speciﬁc functions.
Comparison among species of the measured protein Cys to other
amino acid residues within a sampling of mitochondrial proteins
showed that the Cys are more highly conserved (Fig. 2A) [6].
Examination of the positions of the measured protein Cys within
the three-dimensional crystal structures for homologous proteins
shows that the Cys are often in positions expected to be function-
ally important (Fig. 2B). These include positions near catalytic
sites, protein–protein interaction sites, and RNA-binding or DNA-
interaction sites. Finally, the measured Cys peptides map to
functional pathways according to percentage oxidation (Fig. 3)
[6]. Some speciﬁc examples are discussed in more detail below.
The results are sufﬁcient to conclude that this is a general
phenomenon, although not ubiquitous. Functional networks iden-
tiﬁed include the cytoskeleton, translation, nuclear import, RNA
processing, energy metabolism, and oxidative stress signaling
[6,8,24].
Selective pressure against Cys in protein
Cys codons represent 3.28% of all codons, yet the percentage of
Cys in protein is typically only 2.2% or less [28], indicating that
there is evolutionary selection against utilization of Cys. At the
same time, the percentage of Cys in the proteome is substantially
greater in complex eukaryotes (2.2%) than in archaebacteria and
eubacteria (0.5%) [28]. Cys residues are relatively conserved in
metazoan evolution, leading to the interpretation that much of the
Cys proteome is functional [16]. If such function were restricted to
catalytic or other “active sites,” then one or two Cys within each of
the 20,000 gene products would account for only 10–20% of the
214,000 Cys in the proteome. Instead, the data suggest that up to
80% could be functional, although most without essential “life/
death” function. Alternative functions for Cys include stabilization
of long-lived proteins by formation of Zn clusters [28], presenta-
tion of decoy thiols to protect critical thiols from oxidants and
reactive electrophiles [27], and function as redox-sensing ele-
ments for coordinate regulation of functional pathways [16]. These
are linked together by the concept that the Cys proteome functions
as an interface between the genome and the exposome (Fig. 1) [1].
Speciﬁcally, a Cys proteome network provides a defensive barrier
and sensing system to enhance ﬁtness to tolerate exogenous
oxidants, reactive electrophiles, and toxic trace metal ions and,
at the same time, is used to optimize food utilization.
Early forms of life evolved under signiﬁcantly more reducing
conditions than in the current age of highly efﬁcient photosynth-
esis. Before the evolution of an O2-rich atmosphere between 600
and 900 million years ago, living systems were already utilizing
inorganic sulfur and Cys. Iron–sulfur clusters, for instance, are
ancient prosthetic groups that may have functioned to abiotically
catalyze formation of C–C bonds [29]. Along with the evolving Met
proteome and associated redox reactions to regulate physiology
[30,31], Cys became increasingly utilized with organizational
complexity [28]. Notably, selective pressure against the use of
Cys owing to vulnerability to oxidation is a result of the same
chemical features that confer selective advantage when used as a
redox sensor and switch [28]. The Cys proteome thus enabled the
evolution of systems to regulate O2 availability in tissues and
subcellular compartments as well as support developmental
systems to tolerate and adapt to complex oxidative environments.
Redox compartmentalization
Oxidation of protein Cys occurs within the secretory pathway
as part of a vectorial processing system for proteins targeted to
speciﬁc membrane regions and for protein export [32]. Measure-
ments of steady-state oxidation of proteins show that during
processing, protein disulﬁde isomerase (PDI) is partially oxidized
[33,34]. Recent studies show that a similar redox processing of
Fig. 2. Multiple lines of evidence support function of redox-sensitive Cys measured by mass spectrometry. (A) Targeted searches show that Cys detected in redox proteomic
analyses are highly conserved across metazoans compared to other amino acids in the same proteins. (B) Examination of X-ray crystal structures shows that redox-sensitive
Cys are commonly present in functional motifs of proteins. Examples shown include speciﬁc Cys adjacent to the GTP-binding site in RhoQ, Cys in the RNA binding site of
heteronuclear ribonucleoprotein (HNRNP) A/B, and the DNA interaction site of PCNA. Graphs at the bottom show oxidation in response to challenge with cadmium or
inhibition of thioredoxin with auranoﬁn (Aur) or GSH depletion with buthionine sulfoximine (BSO).
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proteins occurs with mitochondrial protein import [35,36].
Dynamic redox processes are also involved in nuclear protein
import and export [37–39]. These processes depend upon different
control systems, discussed in more detail below, with many
utilizing thioredoxins and thioredoxin-like proteins.
Targeted studies of steady-state oxidation of Trx in subcellular
compartments [40] show that oxidation of Trx differs among major
compartments of mammalian cells, with oxidation in cytoplasm 4
nuclei 4 mitochondria [15,41–44]. Dynamic control within orga-
nelles is illustrated by NF-κB reporter activity being decreased by
generation of H2O2 within nuclei [9] and increased by targeting
peroxiredoxin-1 to nuclei [45]. Increased abundance of nuclear Trx1
in a transgenic mouse model showed increased NF-κB activity and a
proinﬂammatory state potentiating cardiovascular disease [46] and
increased sensitivity to inﬂuenza infection [46]. Thus, control of the
Cys proteome within subcellular compartments has an impact on
Cys reactivity and biologic function.
Functional networks within the Cys proteome
Differences in steady-state oxidation of Trx and glutathione (GSH)
systems among compartments suggest an organizational structure in
Fig. 3. Protein Cys map to functional pathways based upon percentage oxidation. Ingenuity pathway analysis of the most reduced protein Cys in colon carcinoma HT29 cells
under steady-state nonchallenged conditions showed associations with mitochondrial pathways for energy metabolism, cell growth, and proliferation; cytoplasmic
cytoskeletal pathways; and nuclear Ran-import mechanisms and RNA processing. Most oxidized protein Cys were associated with mitochondrial intermediary metabolism,
cytoplasmic cell survival, Myc-mediated apoptosis and 14-3-3 signaling, and nuclear granzyme B signaling. Data from Refs. [6,8,24,49].
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which the central thiol redox systems control subcellular functions.
Studies using mass spectrometry-based redox proteomics revealed,
however, that steady-state percentage oxidation of Cys in proteins
within cytosol, mitochondria, and nuclei mapped to functional net-
works rather than to subcellular compartments [6]. These results
support a role for the Cys proteome in the metabolic and structural
organization of cells, not just as a series of isolated elements in
insulated pathways within subcellular compartments but rather as a
redox network connected throughout the cell.
Emerging data indicate that redox networks coordinate large
numbers of redox elements in function and resistance to environ-
mental challenges. Barabasi and coworkers described metabolic
organization in scale-free hierarchical structures that are inher-
ently stable [47,48]. A bilateral structure for the Cys proteome can
accommodate different oxidant and reductant systems and has
advantages over parallel branching pathways in which protein Cys
residues are physically or kinetically isolated from one another
[6,7]. Furthermore, redox proteomics studies with inhibition of
thioredoxin reductase (TrxR) show that many protein Cys are
simultaneously oxidized [49]. Along with the above evidence for
compartmentalization, and recent data showing that redox path-
ways can switch owing to abundance of reactive targets [50], these
observations indicate that interactions within the Cys proteome
are best described as a network with spatial determinants [6,7].
Redox signaling pathways are present within this network, char-
acterized by being localized [51] and having rapid ﬂux compared
to the relatively slow and distributed election ﬂow of the overall
Cys proteome. We discuss this in more detail below under “Protein
Cys redox regulation, Trx and GSH systems.”
Cys proteome chemistry and functions
Chemical properties of cysteinyl sulfur
The six valence electrons of sulfur in Cys are distributed among
four sp3 orbitals, which consist of two lone pairs and two sigma
bonds with C and H, respectively. Compared to the more abundant
element oxygen, sulfur is less electronegative and has a valence
shell radius nearly twice as large. In the absence of local effects in
protein structure, the thiol of Cys is 5–6 orders of magnitude more
acidic than the hydroxyl group of serine. At physiologic pH, local
environments in proteins can result in predominantly the thiol
(most common) or the thiolate (most reactive) form. Sulfur also
has greater nucleophilicity, with reactivity being substantially
enhanced by ionization and local protein structure. These proper-
ties favor the use of cysteinylate sulfur in biological switching, as it
has increased tendency both to donate electrons and to accept
them [52].
Reactions of protein Cys thiol
Cys thiolate donates an electron pair to thermodynamically
favorable targets resulting in the oxidation of the thiol group.
RSOH, present mostly as sulfanates (RSO-), are a common product
of Cys oxidation and rapidly resolve by reaction with a thiol,
eliminating water to form RSSR. The reaction of RSO with RSH to
form RSSR is 4105 M1 s1 [52]. RSO are central to the
oxidative modiﬁcation of large numbers of Cys targets [25].
Dimeric or internal disulﬁdes often describe a biologically relevant
half-cell with the reduced Cys species to form a redox couple
maintained in nonequilibrium steady state based on interacting
redox couples, compartmentation, cell cycle progression, and
other parameters [40]. In addition to internal disulﬁdes, protein
Cys react with GSH or free Cys to form S-glutathionyl or S-cysteinyl
derivatives, with protein Cys varying in selectivity for these
modiﬁcations versus formation of internal disulﬁdes [53].
The sulfur of Cys can be sequentially oxidized by strong
oxidants, progressing from sulfenic to sulﬁnic and sulfonic acids
(present as RSO2 and sulfonate, RSO3 , respectively). These higher
oxidation states of Cys are signiﬁcantly more difﬁcult to reduce
and may be considered irreversible, although reduction of certain
Cys–SO2 (e.g., peroxiredoxin (Prx)-2) is catalyzed by sulﬁredoxin
[54]. Higher oxidation states are detected in mass spectral analysis
of proteins but the extent of natural occurrence and possible
functions remain unclear.
Cysteinyl sulfur undergoes a variety of other reversible and
irreversible covalent modiﬁcations including nitrosylation, persul-
ﬁdation, alkylation, and arylation that can have unique effects on
Cys redox regulation, function, and signaling (Fig. 4). At least 18
biologically occurring nonradical modiﬁcations of Cys thiol have
been described, including the above reactions. These have widely
varying stability and multiple reviews of their biological impacts
are available [55–57]. A remarkable selectivity in reaction with
different targets highlights the versatility of protein Cys in use. For
instance, the redox sensor Keap1 has multiple Cys residues that
react independently with alkenals, metals, and nitric oxide to
provide a selective detection system [58]. This system also
discriminates acrylamide and H2O2 by reaction with different Cys
residues [59,60]. RS can also be converted to thiyl radicals during
ionizing radiation and other conditions. These radicals rapidly
react with RS and O2 in a series of reactions that convert more
reactive radicals to superoxide [57,61]. A Cys thiyl radical inter-
mediate is used in the catalytic mechanism of all classes of
ribonucleotide reductase, abstracting a hydrogen from the 30
carbon of ribonucleotide ribose to permit deoxygenation at the
20 position for deoxyribonucleotide synthesis [62,63].
In addition to Cys, the genome includes special instructions for
the translation of Sec, the so-called 21st amino acid [64]. Sec is
identical to Cys except for the replacement of sulfur with selenium
(Se). Cys and Sec undergo many comparable reactions, but Se is
much more acidic and nucleophilic than sulfur [65]. Sec is
incorporated into important thiol regulatory and antioxidant
proteins, including TrxR, glutathione peroxidase (GPx), and Met-
R-sulfoxide reductase B1, formerly known as selenoprotein R
[64,66,67]. These interactions warrant inclusion of the selenopro-
teome along with the Cys proteome and Met proteome in broader
considerations of redox systems biology.
Factors affecting protein thiol reactivity
Common chemical features for thiol reactivity exist for reac-
tions involving metal chelation, substrate reduction, and/or con-
jugation or thiol–disulﬁde exchange. Speciﬁc Cys are, however,
often limited to reaction with a fraction of potential thiol-reactive
chemicals, e.g., individual thiols within the same monomeric
protein are selective for thiol–disulﬁde exchange or S-nitrosylation
[68]. Cys reactivity is mediated in part by the overall availability of
the thiolate form because Cys thiol shares its donor electron pair in
a sigma bond with hydrogen. As a consequence, pH and pKa
interdependently regulate cysteinyl sulfur reactivity. For two
hypothetical thiolates in solvent pH 7.4, sharing a reaction
mechanism for H2O2 removal and having pKa 7.4 (50% RS) and
8.4 (9.1% RS), respectively, in the absence of other inﬂuences, the
more acidic thiol reacts approximately 5-fold more rapidly with
the target species. Therefore, pKa exerts inﬂuence on the relation-
ship of a thiol to solvent pH, which differs between subcellular
compartments in eukaryotes. For instance, the mitochondrial
matrix is alkaline at pH 7.8 compared to the intermembrane space,
which is maintained approximately 1 unit lower [69]. This affects
thiol redox potential with speciﬁcity to each thiol. For a thiol–
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disulﬁde half-cell, the effect on the standard redox potential is
5.9 mV/0.1 pH unit. In the case of vicinal dithiols, the effect is
more limited (2.95 mV/0.1 pH) [70]. In vicinal dithiols that
collaborate in a single catalytic function, one is typically more
acidic and the overall behavior depends upon the presence and
characteristics of other reactants. Stable RSO offer another means
of differentiating pH regulation of redox couples, as they tend to
be very strong acids [71]. However, the pKa- and pH-determined
fraction of Cys available as thiolate varies over only a 102-fold
range and thus cannot solely explain the 106-fold range of
reactivity of protein thiols with H2O2 and similar ranges for other
oxidants [72,73].
The nucleophilicity index (determined by highest occupied
molecular orbital and lowest unoccupied molecular orbital) of a
thiol also greatly contributes to its reactivity. Speciﬁcally, a
strongly acidic thiol with poor nucleophilicity may be similar in
reactivity to a weakly acidic thiol with high nucleophilicity [74].
The reactive thiolate species is a “soft” (polarizable) nucleophile
and targets of Cys therefore tend to be “soft” (polarizable)
electrophiles, e.g., 4-hydroxynonenal [74].
Protein Cys are also highly effective in coordinating metal ion
complexes in enzyme active sites and are widely used to regulate
protein structure, maintain metal ion homeostasis, or sequester a
metal toxicant [75,76]. Cys cooperates with inorganic sulfur in
4100 iron–sulfur (Fe–S) proteins, such as ferredoxins and Rieske
proteins [77]. Proximal Cys interaction with heme iron is a
conserved feature of cytochromes P450 (CYP), which enables
monooxygenase activity [78]. Without the coordination of Cys234,
CYP 2B4 is converted to a form with NADPH oxidase activity [79].
Cysteinyl sulfur (alone or in combination with histidine nitro-
gen) coordinates Zn2þ in 3% of human gene products [80]. Cuþ
generally has higher afﬁnity for Cys than other metals, and Cys-
rich metal ion chaperones (e.g., metallothionein and ferritin)
maintain metal ion homeostasis to prevent so-called “mis-metala-
tion” of maturing enzymes [81]. Cys involved in metal ion
coordination also participate in thiol–disulﬁde exchange during
changes in the steady-state potential of cellular antioxidants [82].
Subcellular compartmentalization of metal ions (particularly in the
endomembrane system) is dependent on the expression and
oxidation of cysteinyl redox-active transporters such as sarcoplas-
mic reticulum Ca2þ-ATPase (SERCA) [81,83].
The role of Cys in catalytic sites of enzymes
The ﬂexible reactivity of Cys allows it to confer a range of
functions in enzyme catalytic mechanisms. A common role of Cys
in enzyme catalysis is as a soft nucleophile, acting as the electron
donor for a wide range of substrates. In addition, many proteins
utilize Cys to facilitate protein–protein (e.g., intermolecular dis-
ulﬁde formation), protein–DNA (e.g., promoter binding), and
protein–lipid interactions (e.g., S-palmitoylation) [84–86]. Further-
more, a number of proteins use Cys to permit the inclusion or
function of enzyme prosthetic groups such as heme, Fe, and Zn
[78,87,88], discussed elsewhere in this review. Cys has direct
catalytic involvement in at least ﬁve of the six Enzyme Commis-
sion classes of enzymes as brieﬂy described here and summarized
in Table 1.
Major subtypes of oxidoreductases involving Cys in enzyme
catalysis include disulﬁde exchange, peroxidation, thiyl radical
formation, thioesteriﬁcation, and persulﬁdation (Fig. 4). Each of
these reactions begins with reduced Cys thiol(ate) and involves the
formation of covalent bonds between Cys thiol and substrates
containing carbon, oxygen, sulfur, or phosphorus but not nitrogen,
which bonds with catalytic Cys only as a means of enzyme
regulation. Many of these reactions transfer electrons to or from
NAD(P)H via Cys. Note that whereas the Cys thiol is oxidized in the
Fig. 4. Functional modiﬁcations of the Cys proteome. Protein Cys (R–SH) undergoes a range of enzymatic and nonenzymatic modiﬁcations, often mediated by pH-dependent
ionization to Cys thiolate (R–S; large yellow sphere). Interaction of R–S with metal ions (blue) is common as a structural element, as a binding motif for nucleic acids, and
as a component of catalytic sites. R–S is subject to oxidation ([O]) to Cys sulfenate (R–SO , yellow) by H2O2 and other two-electron oxidants. Thiol (R–SH) also undergoes
exchange with disulﬁde (R1–SS–R1) to generate a different thiol (R1–SH) and disulﬁde (R1–SS–R) in a process termed thiol—disulﬁde exchange. Nonequilibrium steady-state
oxidation of speciﬁc R–SH occurs owing to the presence of low nanomolar concentrations of H2O2 in cells. R–SO reacts with R–SH or GSH to produce the respective
disulﬁdes (R–SS–R, R–SSG; dark yellow, top). Many R–SO can undergo hyperoxidation to sulﬁnate (R–SO2; orange, bottom) and sulfonate (R–SO3; red) in the presence of
excess oxidant. R–S also reacts with nitric oxide through multiple means of nitronium ion transfer (NOþ) to produce a corresponding nitrosothiol (R–SNO; orange, bottom
left). R–SO can also react with hydrogen sulﬁde (HS) to form a cysteinyl persulﬁde (R–SS , green), which can be oxidized to a cysteinyl thiosulfate (R–SSO3). Alternatively,
R–SO can react with primary amines of neighboring amino acids or separate biomolecules to form sulfenamide (R–SNRH), which can be further oxidized to sulﬁnamide (R–
S(O)NRH) and sulfonamide (R–S(O)2NRH), frequently resulting in cyclic intramolecular structures.
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initial step of all of these reactions, the substrates and catalytic
cycle determine whether energy (often in the form of NADPH) is
generated or consumed.
Protein Cys thiyl radicals are known to occur only in ribonucleo-
tide reductases (RNRs), which are essential for DNA synthesis in all
kingdoms of life [63]. All RNRs utilize a Cys thiyl radical to initiate
the catalytic cycle but differ in how it is generated: class I RNR
utilizes a stable tyrosyl radical, class II utilizes adenosylcobalamin,
and class III utilizes a glycyl radical generated by Fe–S clusters and
S-adenosylmethionine [63]. The Cys thiyl radical initiates reaction
by oxidizing C3 of ribonucleotide ribose. The carbon-centered
radical shifts to C2, dehydrates, and undergoes one-electron reduc-
tion (again forming a radical) by a pair of additional Cys residues.
Finally, the radical oxidizes the initiating Cys, regenerating the
original thiyl radical and releasing deoxyribonucleotide [62].
Disulﬁde- and peroxide-reducing functions of catalytic Cys
have been extensively reviewed. These reactions transfer electrons
to substrate sulfur or oxygen in an oxidation state of 0 (RSOH
sulfur) or 1 (RSSR and peroxides). The result is formation of
disulﬁde or RSOH on the nucleophilic Cys and the liberation of
RSH, H2O, or ROH from the substrate. The initiating Cys, typically
oxidized to RSSR, must then be reduced to regenerate the enzyme.
These reactions make up the bulk of redox regulation by members
of the TrxR and glutathione reductase (GR) antioxidant nodes.
These reactions are also found in important chaperone proteins,
such as protein-disulﬁde isomerase, which are classiﬁed by the
Enzyme Commission as isomerases because they rearrange protein
disulﬁdes rather than cause net oxidation or reduction [89].
Sulfurtransferases are proteins that catalyze the formation,
interconversion, and reactions of compounds containing sulfane
sulfur atoms [90]. Although characterization of many is incomplete,
Cys persulﬁde (Cys–SSH) is an important catalytic intermediate for
some [91]. The catalytic Cys is persulﬁdated by thiosulfate, hydro-
gen sulﬁde, or mercaptopyruvate, creating a highly reactive sulfur
donor, which produces low-molecular-weight sulfur metabolites
such as thiocyanate (SCN-) and methanethiol [92]. H2S can be
liberated from the Cys persulﬁde as well as the original persulﬁde
donor [92]. As persulﬁdation is also a putative peptidyl Cys
regulatory mechanism, it is covered elsewhere in this review.
Catalytic Cys-formed thioesters fall into two classes: thioacyl
esters (S–CR bond) and thiophosphate esters (S–PO3 bond).
Thioacyl esters are intermediates of aldehyde dehydrogenases
(ALDHs) and cysteine protease catalytic cycles. In the case of
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and ALDH,
Cys thioacyl formation is preceded by a thiohemiacetal intermedi-
ate that donates a hydride to NADPþ [93]. Similarly, Cys proteases
attack the amide carbon peptide backbones at select residues (e.g.,
aspartate), causing cleavage of the amide bond [94]. Cys proteases
are unlike Asp proteases in that they do not participate in classical
acid–base hydrolysis. Rather, the Cys thioacyl ester provides a
good leaving group to facilitate hydrolysis and protease regenera-
tion. Similarly, the Cys–SPO3 thiophosphate ester formed after
nucleophilic attack on phosphotyrosine in the protein tyrosine
phosphate (PTP) catalytic cycle is an excellent leaving group [95].
However, as in acid–base catalysis, these reactions are supported
by negatively charged side chains such as Asp and Glu, which
coordinate the protonation of water, substrates, and Cys itself.
Protein Cys redox regulation
Trx and GSH systems
Extensive research in the past decades shows that redox
responses of the Cys proteome occurring at the extracellular and
cellular levels are critical in the initiation and progression of
disease. Two major cellular redox regulation systems, dependent
Trx and GSH, are central to the regulation of the Cys proteome.
These systems maintain a reduced redox environment in cells by
catalyzing electron ﬂux from NADPH through TrxR and GR to Trx
and GSH, respectively. In addition, mixed disulﬁdes of GSH with
protein Cys (S-glutathionylation) can have a broad impact on
protein function and disease [88]. S-glutathionyl groups are
removed by glutaredoxin (Grx) plus GSH. In some cases Grx may
transfer electrons from the GR–GSH node into the TrxR–Trx node
by reducing Trx disulﬁde [96]. Numerous studies of Cys modiﬁca-
tion and redox regulation provide evidence that redox-sensitive
regulatory Cys residues (see Fig. 5 legend) play critical roles in cell
signaling and control as part of a redox network structure. These
systems are involved in multiple signaling pathways through
direct or indirect interactions with a variety of target proteins
controlled by the GSH and Trx redox systems (Fig. 5). Proteins and
associated protein networks are often selectively regulated by Trx
or GSH systems but also commonly regulated by both GSH and Trx
systems, e.g., S-glutathionylation in C374 and S-nitrosylation in C285
of actin (Fig. 5).
Table 1
Cys in catalytic sites of enzymes.
Function Enzyme Substrate(s) Ref.
Oxidoreductase GR GSSG [251]
Grx GSS–Cys, Trx–SS [96,252]
GPx Lipid, inorganic peroxides [64]
GST Electrophiles, lipid peroxides [253]
TrxR Trx–SS [64]
Prx Peroxides [60]
GAPDH G3P [59]
ALDH Aldehydes [93]
RNR (radical-mediated reduction) Ribonucleotides [63,254]
Transferase Thiosulfate sulfurtransferase, mercaptopyruvate sulfurtransferase H2S, S2O3, mercaptopyruvate [91]
Thymidylate synthase dUMP [255]
Hydrolase γ-Glu hydrolase γ-Glu peptides [256]
Caspases, cathepsins, calpains Polypeptides [94]
PTP, Cdc25 pTyr [176]
Isomerase PDIs RSSR-X-X-X-RSH [89]
Ligase Parkin E3 ubiquitin ligase Cys-His-Glu [257]
The sulfur of Cys functions in the active site of at least ﬁve of the six classes of enzymes classiﬁed by the Enzyme Commission. These include various types of oxidoreductases
linked to the NADP or NAD system and also radical-mediated ribonucleotide reduction. Cys functions in the transfer of sulfane in some transferases. Cys is present in the
active sites of hydrolases, such as cysteine proteases and phosphatases. Protein disulﬁde isomerases (PDIs) catalyze the rearrangement of thiol and disulﬁde bonds without
any net oxidation or reduction. Some ligases have active-site Cys functioning in covalent bond formation.
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As indicated above, mass spectrometry-based redox proteomics
together with bioinformatics enables identiﬁcation of redox-
sensitive Cys residues, proteins, and networks of the Cys proteome
in association with cellular conditions [6,8,49]. Studies in yeast
showed that the redox proteome was preserved in cells deﬁcient in
the GSH system but not in cells with compromised Trx systems.
These results show that the Trx system is most central in regulation
of the yeast Cys proteome [97]. In mammalian cells, responses of
the Cys proteome were tested by selectively disrupting the Trx- and
GSH-dependent systems with inhibitors, auranoﬁn for thioredoxin
reductase and buthionine sulfoximine for γ-glutamylcysteine
synthetase, the ﬁrst enzyme in the GSH synthesis pathway. Results
showed that the Trx and GSH systems support distinct functions in
cellular redox control by controlling different subsets of protein Cys.
Consistent with the yeast ﬁndings, the Trx system regulated a much
broader range of proteins than the GSH system [49]. However, GSH
and Grx can act as a backup to the TrxR–Trx system to promote the
reduction of Trx during aurothioglucose exposure [96]; the extent
to which this alters redox proteomic effects of TrxR inhibition is
unclear. Examples from studies with selective inhibition of TrxR and
GSH systems are available [49,98].
Regulation of actin cytoskeleton proteins
Cytoskeleton remodeling through actin dynamics regulates vital
biological processes, e.g., cell morphogenesis, migration and growth,
membrane trafﬁcking, exocytosis, and endocytosis [99–101]. Actin is
susceptible to multiple posttranslational modiﬁcations in Cys resi-
dues including reversible thiol oxidation (Cys217, 257, 272, 285, 374)
[102–104], glutathionylation (Cys10, 217, 257, 374) [105–107], and
nitrosylation (Cys217, 257, 285, 374) [108–110]. Oxidation disrupts actin
dynamics, e.g., ﬁlamentous (assembled) and monomeric (disas-
sembled) actin formation [111,112]. Glutathionylation/deglutathio-
nylation of actin, regulated by the concentration of GSH and Grx
activity, is also associated with actin dynamics [113–115].
In addition to actin itself, a cohort of actin-associated cytoske-
letal proteins controls actin dynamics. Oxidation of Cys139 and
Cys147 in actin-binding protein coﬁlin stimulates apoptotic signal-
ing as a consequence of inhibiting interaction with actin as well as
increasing mitochondrial translocation [116], and coﬁlin oxidation
impairs cytoskeletal function in T cells [117]. Furthermore, destrin,
a coﬁlin family member, is an actin depolymerizing factor regu-
lated by Cys redox status. Destrin nuclear translocation was
associated with redox disruption of the actin cytoskeleton pro-
teome [8]. Actin cytoskeleton proteins were also susceptible to
oxidation during inﬂammatory signaling associated with mito-
chondrial oxidation [6,22]. Redox-dependent control of actin
dynamics was observed from the interaction of actin with the
Trx system, Trx1 and TrxR1 [110,118,119]. Release of Trx1 from
actin resulted in degradation of Trx1, which then stimulated cell
death [119]. Denitrosylation of actin by TrxR via focal adhesion
kinase restored cellular function [110].
Extensive knowledge of the redox modulation of the cytoske-
leton by the GSH and Trx systems shows the central importance of
Fig. 5. Cys proteome networks regulated by the Trx and GSH systems. Accumulating evidence shows that redox networks exist in different subcellular compartments
supported by NADPH as a reductant functioning in opposition to oxidation by H2O2 and other oxidants. Trx is the most common intermediary reductant, with a smaller
number of proteins supported by GSH. Cysteine and cystine constitute the most abundant extracellular low-molecular-weight thiol/disulﬁde couple, apparently functioning
in the regulation of protein Cys on the extracellular surface. References provide detailed information on the interactions of Cys proteins and functional Cys residues: TrxR–
actin [110], Trx-dependent regulation of proteins [139], Ref1–AP1 [258], TrxR/AP1 [259], PDGFR [260], xCT [261], PTEN–Trx [262,263], PTEN–GSH [264], ASK1–Trx2 [264],
GSTp1–Prx6 [265], GAPDH–GSH [266,267], ND–GSH [268], p53–Trx [269], Trx2–Prx3 [270], Srx–Prx1 and Srx–Prx3 [271,272], Grx2–Prx3 [273], Grx2–Prx3–Trx2 [274], PDI–
UPR sensor [275], Era–PDI [276], PDI–TF [277], Ero-α-PDI and GSH [278], GPx7–ER [279], Nrf2 regulatory Cys residues [280], Srx functional Cys residues [281].
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redox control in cell function. The data demonstrate that GSH and
Trx do not indiscriminately “equilibrate” the peptidyl Cys environ-
ment to a consistent reduction potential but sensitively and
selectively maintain discrete nonequilibrium dynamics for indivi-
dual proteins and protein networks. The following examples
further illustrate the use of kinetically controlled systems in
nuclear protein trafﬁcking and in maintenance of the integrity of
the genome. Recent reviews are also available on the redox
processing in the secretory pathway [33,34,120] and in mitochon-
drial import [35,36]. Relatively less information is available on
vectorial redox processing during endocytosis and proteolysis in
lysosomes, but evidence is available suggesting that analogous
systems are present [121,122].
Cys proteome in nuclear protein trafﬁcking
Redox-dependent transcription has been known for many
years, with divergent mechanisms involved for AP-1, Nrf2, NF-
κB, glucocorticoid receptor, and other systems [38,123–126]. Both
Trx1 and its inhibitory binding partner Txnip (Trx-interacting
protein/vitamin D3-upregulated protein) are translocated into
nuclei to regulate the Cys proteome. For instance, nuclear accu-
mulation of Txnip was detected when cells were treated with the
anti-cancer histone deacetylase inhibitor suberoylanilide hydro-
xamic acid [127]. Rch1 (importin-α) is required for Txnip nuclear
translocation and growth control, and this interaction is controlled
by a Trx-dependent redox system [128]. Interestingly, Trx1 is also
translocated into nuclei, and import requires karyopherin-α
(importin-α) and nitric oxide (NO). Site-directed mutagenesis of
Lys81, 82 of Trx1 showed that these residues are important for the
translocation of Trx1 into nuclei [129], suggesting that the protein
translocation mechanism is complex, requiring localized signal
motifs in addition to redox-dependent regulation.
In addition to enhanced Trx1 translocation to nuclei, transport
and translocation of a wide range of proteins are regulated in a
redox-dependent manner. For instance, oxidative stress stimulates
nuclear translocation of SBP2 (selenocysteine insertions sequence
binding protein 2) via oxidation of Cys within a redox-sensitive Cys-
rich domain. Reversal by Trx1 or Grx suggests that the redox state of
SBP2 is critical to compartmental translocation and selenoprotein
synthesis [130]. In bronchopneumonia, protein S-glutathionylation
signiﬁcantly colocalized with Fas ligand, and Grx1-knockout mice
had increased Fas S-glutathionylation and improved murine lung
infection survival [131]. Mass spectrometry-based redox proteomics
also showed functional redox networks of nuclear import proteins
(Fig. 3) [6]. Additionally, targeted expression of nuclear Trx1, stimula-
tion of nuclear H2O2 production with nuclear-targeted D-amino acid
oxidase, and enhanced nuclear peroxidase activity by expression of
nuclear-targeted Prx1 further show distinct redox control in nuclei
[9,45]. Thus, multiple approaches show that the nuclear Cys pro-
teome is controlled in a semiautonomous manner by transport and
compartment-speciﬁc regulation.
Nuclear functions of the Cys proteome
The dynamic nature and functional importance of
compartment-speciﬁc control of the Cys proteome are further
illustrated by Trx-dependent protection against cellular stresses
associated with growth inhibition and cell death induced by H2O2,
TNFα, and chemotherapeutic agents [132–134]. Txnip directly
binds to Trx1 by forming a disulﬁde bond between Cys247 of Txnip
and catalytically active Cys residues of Trx (Cys32 and Cys35),
inhibiting the redox activity of Trx [135,136]. The complex
of Txnip-bound Trx contributes to the pathogenesis of
multiple diseases including diabetes, autoimmune disease,
and cancer [137–139]. Upregulation of Txnip under sustained
high-glucose exposure caused increased reactive oxygen species
generation and caspase-3 activation [140]. The pathological role of
Txnip was revealed with the release of Txnip from oxidized Trx1 to
stimulate inﬂammation [141] and cell death [140]. Similarly, the
reduced form of Trx1 binds to apoptosis signal-regulating kinase-1
(ASK-1) and inhibits its activity to prevent stress- and cytokine-
induced cell death [142]. Activation of ASK-1 is stimulated under
stress signaling after dissociation with Trx1 [142] and plays a key
role in apoptosis with increased DNA damage [143,144]. Direct
interaction of Trx with Txnip (Cys247) and ASK-1 (Cys250) via
reduced Cys32 (Cys30 of Trx2) supports a key role for the Trx
thiol–disulﬁde redox regulatory function against oxidative stress-
mediated DNA damage and cell death signaling [141].
Trx1 also plays a key role in DNA repair mechanisms by
regulating the base excision repair pathway via the p53 down-
stream gene, growth arrest, and DNA-damage-inducible protein
45α and its interaction with apurinic/apyrimidinic endonuclease 1
(also called redox factor (Ref)-1) [145]. This mechanism is regu-
lated by the interaction between Trx1, Ref-1, and redox-sensitive
p53 transcription factor [146,147]. TrxR–Trx1 also interacts with
Ref-1, and this interaction controls p53 activity supporting the
Trx1 redox system in modulation of redox-sensitive transcription
factors [148]. Moreover, Trx1 protection against cell death was
shown to occur in growth regulation in B cell chronic lymphocytic
leukemia by controlling the interaction of protein disulﬁde iso-
merase with tumor necrosis factor receptor [149]. This ﬁnding
additionally supports the beneﬁcial role of Trx1 in survival,
perhaps via activation of NF-κB transcription factor [147].
Oxidation of the Cys proteome by H2O2 and derivative species
Measurements of bulk protein Cys in mouse liver and HT29 cell
culture show that 92 and 88%, respectively, are in the thiol form
[6]. With procedures to minimize artifacts in mass spectrometry
measurements, similar mean (84.3%) and median (87.7%) values
were obtained for HT29 cells in culture. Speciﬁc protein Cys had a
distribution of steady-state oxidation ranging from less than 8% to
greater than 99% reduced. These observations raise key questions
about the oxidants involved and the underlying enzymatic and
nonenzymatic mechanisms contributing to steady-state oxidation.
The balance of oxidation and reduction of the Cys redox
proteome are governed by the thermodynamics, selectivity, and
kinetics of various peptidyl Cys. As indicated above, details of the
reduction systems are becoming clear. In contrast, the ﬁne-tuned
oxidative signaling has been ascribed extensively to H2O2, a
species that is relatively unreactive with most Cys thiols. At least
three factors inﬂuence the speciﬁcity of oxidation, i.e., localized
high-activity generation of H2O2, catalytic mediators of oxidation,
and generation of alternative low-molecular-weight chemical
oxidants. Enzymes with high reactivity with H2O2 (e.g., members
of the Prx and GSH S-transferase (GST) families) may act as special
carriers of the oxidative signal to interacting proteins [150].
Alternatively, H2O2 is used to generate other oxidants with altered
kinetics (e.g., hypohalous acids) [151], which in turn can form
further derivative oxidizing species (e.g., haloamines). These
processes support speciation of an H2O2 oxidative signal into
various paths, which regulate not only the fate of H2O2 but also
the effect of its oxidative signal.
H2O2
Although O2 is present at 5 orders of magnitude higher
concentration than H2O2 in aerobic organisms, H2O2 is usually
considered the most central oxidant in the maintenance of steady-
state oxidation of the Cys proteome. H2O2 is a product of at
least 31 human enzymes (Table 2) and has been measured in
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mammalian tissues at concentrations in the range of 1 to 50 nM
[152–155]. Measurements of H2O2 based upon steady-state
kinetics of endogenous catalase in perfused rat liver developed
by Sies and Chance [156] may be the most reliable tissue
measurements available because there are no possible artifacts
due to transfection or calibration of imaging reagents. Catalase
concentration is too low to support this type of measurement in
most cells and tissues, however, and more sensitive ﬂuorescent
probes have been widely used. Some, such as dichloroﬂuorescein
diacetate, are nonspeciﬁc and require caution when evaluating cell
and tissue H2O2 production. Other probes can also be nonspeciﬁc,
insensitive to rapid ﬂux changes, or misleading owing to redis-
tribution of probes within cells [157]. In contrast to high reactivity
of H2O2 with peroxiredoxins, GSH peroxidases, and catalase, H2O2
reacts quite slowly with the majority of thiols. For low-molecular-
weight thiolates, the rate constant of reaction with H2O2 is about
20 M1 s1 but the effective rate constant for total thiol (thiol þ
thiolate) is o5 M1 s1 [158]. Using 5 M1 s1, total protein Cys
at 20 mM, and H2O2 at 10 nM, noncatalytic oxidation of protein
Cys by H2O2 in cells occurs at 0.0003% per minute. This rate is too
slow to maintain the steady-state oxidation as indicated above.
Multiple alternatives exist that could account for higher steady-
state oxidation, e.g., a fraction of protein Cys with higher rate
constants, more reactive oxidants derived from H2O2, or catalytic
oxidation of protein Cys by peroxiredoxins, glutathione S-trans-
ferases, or other enzymes in the presence of H2O2. Studies of
various protein Cys show that rate constants for the reaction with
H2O2 vary over more than 6 orders of magnitude [57]. A network
model of H2O2 clearance with 24 elements and 28 kinetic para-
meters including pseudo-enzymatic oxidative turnover of protein
thiols; the enzymatic actions of catalase, glutathione peroxidase,
peroxiredoxin, and glutaredoxin; and the redox reactions of Trx
and GSH correctly reproduced experimentally measured oxidation
proﬁles for the GSH and Trx redox couples [159]. The model
suggested that approximately 10% of intracellular protein thiols
react with H2O2 at substantial rates and predicted an unequal
distribution of the intracellular antioxidative burden between Trx-
dependent and GSH-dependent antioxidant pathways, with the
former contributing the majority of the cellular antioxidant
defense due to Prx and protein disulﬁdes. Importantly, if enzymes
with peroxidase activity, such as the Prx and GST families, use
protein Cys as a direct reductant, supported by Trx or GSH systems
to reduce the protein Cys back to thiol form, then a complete
enzymatic system exists to maintain the dynamic Cys proteome
[7]. The overall organizational structure is one in which the Cys
proteome is not collectively equilibrated with NADPþ/NADPH,
with O2/H2O, or at any single redox potential. Instead, a continuum
of kinetically limited nonequilibrium steady states exists for
protein Cys, varying in abundance and spatial and temporal
distributions [40].
The system is dynamic and responds to changes in H2O2 during
inﬂammation and signaling for proliferation, cell migration, or
host defense [151,160–162]. Research shows substantial circadian
variation [163], changes during development [164], and spatio-
temporal temporal changes during wound healing [165]. The
oxidative second messenger [166] with localized generation [51]
is ampliﬁed by a “ﬂoodgate” mechanism [167] involving excessive
oxidation of Prx and Trx1 (see below) [168]. This mechanism could
alter redox signaling by diverting H2O2 ﬂux to oxidize other
proteins or, perhaps more likely, support enzymatic oxidation or
other redox-activated signaling mechanism [166].
Earlier analytic methods detected only protein disulﬁdes;
development of reagents for trapping RSO , however, showed
that RSO is the predominant modiﬁcation of the Cys proteome
Table 2
Hydrogen peroxide-generating human enzymes.
Name Protein Gene Accession No. Location Product
Aldehyde oxidase ADO AOX1 Q06278 C H2O2
Amine oxidase (ﬂavin-containing) A AOFA MAOA P21397 M H2O2
Amine oxidase (ﬂavin-containing) B AOFB MAOB P27338 M H2O2
D-Amino acid oxidase OXDA DAO P14920 Px H2O2
L-Amino acid oxidase OXLA IL4I1 Q96RQ9 L H2O2
D-Aspartate oxidase OXDD DDO Q99489 Px H2O2
Amiloride-sensitive amino oxidase (copper containing ABP1 ABP1 P19801 S H2O2
FAD-linked sulfhydryl oxidase ALR GFER P55789 C, M, S H2O2
Hydroxyacid oxidase 1 HAOX1 HAO1 Q9UJM8 Px H2O2
Hydroxyacid oxidase 2 HAOX2 HAO2 Q9NYQ3 Px H2O2
Membrane primary amine oxidase AOC3 AOC3 Q16853 PM H2O2
Peroxisomal N1-acetylspermine/spermidine oxidase PAOX PAOX Q6QHF9 Px, C H2O2
Peroxisomal acyl-coenzyme A oxidase 1 ACOX1 ACOX1 Q15067 Px H2O2
Peroxisomal acyl-coenzyme A oxidase 3 ACOX3 ACOX3 Q15254 Px H2O2
Peroxisomal sarcosine oxidase SOX PIPOX Q9P0Z9 Px H2O2
Prenylcysteine oxidase 1 PCYOX PCYOX1 Q9UHG3 L H2O2
Protein-lysine 6-oxidase LYOX LOX P28300 S H2O2
Pyridoxine-5-phosphate oxidase PNPO PNPO Q9NVS9 C H2O2
Retina-speciﬁc copper amine oxidase AOC2 AOC2 O75106 PM, C H2O2
Spermine oxidase SMOX SMOX Q9NWM0 C, N H2O2
Sulfhydryl oxidase 1 QSOX1 QSOX1 O00391 G H2O2
Sulfhydryl oxidase 2 QSOX2 QSOX2 Q6ZRP7 N, PM, S H2O2
Sulﬁte oxidase, mitochondrial SUOX SUOX P51687 M H2O2
Xanthine dehydrogenase/oxidase XDH XDH P47989 C, Px, S H2O2
NADPH oxidase 1 NOX1 NOX1 Q9Y5S8 PM O2
Cytochrome b245 heavy chain (gp91phox) CY24B (NOX2) CYBB P04839 PM O2
NADPH oxidase 3 NOX3 NOX3 Q9HBY0 PM O2
NADPH oxidase 4 NOX4 NOX4 Q9NPH5 E, PM, N H2O2
NADPH oxidase 5 NOX5 NOX5 Q96PH1 E O2
Dual oxidase 1 DUOX1 DUOX1 Q9NRD9 PM H2O2
Dual oxidase 2 DUOX2 DUOX2 Q9NRD8 PM H2O2
Enzymes producing superoxide anion (O2) are included because O2 is commonly dismutated to produce H2O2. Abbreviations used for subcellular localization: C,
cytoplasm; E, endoplasmic reticulum; G, Golgi; L, lysosome; M, mitochondria; N, nucleus; PM, plasma membrane; Px, peroxisome; S, secreted. Other proteins are likely to
produce O2 or H2O2 but not included owing to limited characterization. Enzymes generating lipid peroxides are not included.
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[25] and central to oxidative Cys regulation (Fig. 4). For instance,
RSO in multiple PTPs is associated with inhibition of CD8þ T cell
activation [169], and formation of RSO in IQGAP1 plays a direct
role in endothelial cell migration and angiogenesis [170]. Recent
bioinformatics analysis using a dimedone-tagged click chemistry
probe has revealed multiple peptidyl Cys with basal RSO mod-
iﬁcation, including Cys18 of SIRT6 and multiple Cys of pyruvate
kinase M2 [26]. RSO were detected in solvent-accessible peptidyl
Cys from proteins associated with most subcellular compartments
and included enzymes regulating phosphorylation, acetylation,
and ubiquitylation [26]. Peptidyl Cys with detectible RSO mod-
iﬁcation were often associated with Glu and Lys residues and less
often with other Cys residues [26].
Oxidation of RSO to RSO2 (sulﬁnate) in peroxiredoxin has a
special role in signaling because this oxidation inhibits peroxidase
activity, redirects reducing equivalents from the Trx system away
from Prx2, and changes protein Cys redox regulation [171]. This
process is termed “hyperoxidation,” and detailed studies with
Cys50 of Prx2 [172], including thermodynamics and contributions
of proximal amino acids [60,73,173,174] are available to describe
the underlying mechanism. Ultimately, hyperoxidation of Prx2
diverts H2O2 to other antioxidant systems. Such diversion alters
redox signaling by changing elements of the Cys proteome that
react with oxidant [166]. Furthermore, hyperoxidation of Prx2 is
biochemically regulated, as sulﬁredoxin reduces Prx2 Cys sulﬁnate
back to the sulfenate form, which may be reduced by Trx [54].
The Cys proteome includes sulﬁnic and sulfonic acids, as well as
series of sulfenamides, sulﬁnamides, and sulfonamides. With the
exception of sulﬁnic acid and possible precursor RSONR2 [175] in
peroxiredoxins, there is little evidence that these represent func-
tional variations. Similarly, cyclic sulfonamide (isothiazolidinone)
structures are formed from the catalytic Cys of certain phospha-
tases, e.g., Cys215 of PTP1B [175,176], but the functional and
physiologic relevance of these is unclear. Cysteinyl sulfur and
amine interaction also provides a means to cross-link molecules
by strong oxidants, observed in model Cys-containing peptides
and GSH and in vivo [177–179]. Thiosulﬁnates and thiosulfonates
are documented in thiol chemistry [52], and thiosulﬁnate has been
found as an intermediate of the sulﬁredoxin (Srx) Cys99 reduction
of Prx2 sulﬁnic phosphoryl ester [180]. Thus, a diverse range of
oxidized sulfur and sulfamine modiﬁcations of the Cys proteome
can occur, but only a very small number have been characterized
in terms of biologic functions.
Oxidant species derived from H2O2
The Cys proteome is subject to oxidation by peroxide-derived
oxidants, some of which have similar thermodynamic potential
but lesser kinetic limitations than H2O2. Hypohalous acids (hypo-
chlorous acid, HOCl; hypobromous acid, HOBr) are strong oxidants
generated by phagocytic myeloperoxidase (MPO) during inﬂam-
mation and widely recognized as dual agents of host defense and
host injury [151,181]. HOCl and HOBr rapidly react with thiolates
by transfer of Clþ or Brþ [52]. The resulting sulfenyl halide is
unstable and rapidly hydrolyzes to release Cl or Br and RSO
[182]. Similarly, eosinophil peroxidase is released in allergic events
and generates HOBr, but little or no HOCl at physiologic pH
[183,184].
Low-level generation of HOCl and HOBr can also occur in
tissues without inﬂammation via the activity of peroxidasins (also
known as vascular peroxidases), which participate in collagen
cross-linkage and are essential for tissue development [185–188].
However, the impact of constitutive HOCl and HOBr generation on
Cys proteomic regulation has not been extensively characterized.
In principle, these oxidants could oxidize selected subsets of the
Cys proteome as suggested by the ﬁnding that HOCl independently
activates Nrf2 and MAPK signaling in airway epithelia [189]. A
potential limitation for speciﬁc Cys oxidation is that HOCl and
HOBr have high and indiscriminate reactivity with most Cys [190]
and also react with non-Cys residues, e.g., Met and primary amines
[191,192]. On the other hand, conversion of hypohalous acids into
less reactive haloamines (e.g., RNHCl) may confer speciﬁcity. For
instance, taurine chloramine oxidizes Cys282 of creatine kinase
with threefold increased selectivity compared to HOCl [193].
Hypothiocyanous acid (HOSCN) is a related oxidant that is
constantly produced from endogenous SCN, lactoperoxidase (LPO),
and H2O2 in human secretory ﬂuids (e.g., saliva, airway lining ﬂuid,
tears, and milk) [194–196]. HOSCN has been studied extensively in
saliva and is maintained at concentrations greater than ﬁvefold
more abundant than the precursor H2O2 [197]. In addition to
enzymatic production by LPO, MPO, and other peroxidases
[186,282], HOSCN is produced by the direct reduction of HOCl or
HOBr by SCN , a reaction that competes effectively with physio-
logic concentrations of GSH [52,198]. HOSCN reacts with protein
Cys to form RSO and SCN [52,198].
The most critical aspect of HOSCN is that it is signiﬁcantly less
reactive than H2O2, HOCl, or HOBr [173,199–201], which suggests
greater speciﬁcity for Cys proteomic regulation. Support for this
possibility is limited, but HOSCN, and not HOCl or HOBr, induces
cell signaling by reaction with serum factors [202,203]. HOSCN
selectively targets salivary GSTP, but not GSTA or GSTM [204].
Altered redox signaling of HOSCN may be reﬂected in altered
cellular responses to this oxidant instead of others, e.g., removal of
H2O2 and HOCl by SCN protects against mammalian cell death
and decreases inﬂammation [179,205]. Furthermore, mammalian
innate immunity exploits speciﬁcity of HOSCN reactivity to place
selective oxidative pressure on microbes [206]. The biochemical
and physiological effects of SCN and HOSCN have been recently
reviewed [207].
S-Nitrosylation
Nitric oxide is a precursor for S-nitrosylation of the Cys
proteome, governed by multiple reaction pathways, e.g., metal
catalysis of NOþ transfer, with the ultimate action being formation
of protein S-nitrosocysteine (RSNO). S-nitrosylation is regulated by
the GSH and Trx systems, which reduce RSNO [208,209]. Trans-S-
nitrosylation is important in NO signaling and as a negative
feedback mechanism for NO synthases and effector proteins
[209]. SERCA is nitrosylated at Cys344 and Cys349 after ONOO
exposure, which enhances subsequent protein glutathionylation
[210]. The oxidation of critical SERCA Cys residues, e.g., S-
nitrosylation and S-glutathionylation, may be a guanylate
cyclase-independent means to alter vascular tone [211]. Skeletal
muscle ryanodine receptor/Ca2þ-release channel Cys3635 is regu-
lated by S-nitrosylation, whereas other Cys mediate redox sensi-
tivity through SNO-independent means [209,212,213]. Several
mitochondrial metabolic enzymes are targets of S-nitrosylation
[214]. Thus, S-nitrosylation represents a series of modiﬁcations of
the Cys proteome, which can be considered parallel to the
oxidative systems in providing a network of regulatory elements
inﬂuencing diverse aspects of cell function.
Persulﬁdation
Persulﬁdation, also termed S-sulfhydration [215,216], is another
mechanism for modiﬁcation of the Cys proteome that can operate
in parallel with the oxidative and S-nitrosylation systems. The
protein persulﬁde (RSS) is derived from H2S generated from Cys
via intestinal microbes, mercaptopyruvate sulfotransferase,
cystathionine β-synthase (CBS), and cystathionine γ-lyase (CGL)
[217,218]. At physiologic pH, H2S is principally ionized (HS) and
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reacts with a disulﬁde to produce RSS and release a thiol. For
instance, GSH persulﬁde (GSS) is formed from the reaction of
GSSG with H2S [219]. The sulfur added to the thiol in the persulﬁde
moiety is present at the oxidation state of elemental sulfur
(sulfane), which commonly exists as octasulfane (S8). Cysteinyl
polysulﬁdes have been documented in crystal structures of bacter-
ial sulﬁde quinone oxidoreductases [215], and free polysulﬁdes
(H2Sn) in brain tissue can persulﬁdate multiple protein Cys targets
[220]. Sulfane sulfur can be transferred between protein thiols and
low-molecular-weight thiols (trans-persulﬁdation or trans-sulfa-
nation). The extent of persulﬁde modiﬁcation of proteins is
currently unknown [221,222].
Persulﬁde formation generally interferes with normal protein
Cys reactivity in much the same way as S-nitrosylation or
sulfenylation [223] but differs in that the highly nucleophilic
auxiliary sulfane is more reactive toward electrophiles [224].
Inhibition of H2S generation leads to mitochondrial dysfunction
and increased O2 ﬂux, suggesting a role for H2S in regulation of
mitochondrial function [225]. Persulﬁdation of 39 proteins, includ-
ing GAPDH Cys150, was detected by mass spectrometry [226].
Persulﬁdation of GAPDH Cys150 by treatment with NaSH increased
enzyme activity, with an EC50 of 15 mM; GAPDH is also an S-
nitrosylation target, highlighting a potential for H2S/NO cross talk
[226]. After TNFα stimulation of CGL, increased persulﬁdation of
p65 Cys38 regulated its DNA binding and antiapoptotic function
[227]. The C59S mutant of P66Shc is resistant to antiphosphoryla-
tion effects of H2S or CBS overexpression, implicating regulation by
persulﬁdation [228]. H2S also regulates endothelial NO synthase
(NOS) activity by persulﬁdation of Cys443, which promotes activity
of NOS in opposition to NO binding [216].
Alkylation
Many modiﬁcations of the Cys proteome are irreversible under
normal circumstances in vivo. Some of these, such as modiﬁcation
by endogenously derived reactive lipids, function to provide a
response to stress [229]. Reactive aldehydes make up a highly
signiﬁcant and well-recognized fraction of permanent Cys adduc-
tion [230]. Many α/β-unsaturated aldehydes such as 4-
hydroxynonenal (4-HNE) are “soft” electrophiles that react readily
with soft nucleophiles and are chieﬂy regulated in vivo by Cys
thiolate [74,174]. 4-HNE reacts with Cys residues of many impor-
tant proteins. The thioredoxin system, including TrxR (Cys496
along with Sec497 [65]) and Trx (Cys32, Cys35), is very sensitive to
inhibition by 4-HNE [231]. Similarly, the catalytic and modifying
subunits of Glu–Cys ligase (GCLC/M) are targets of 4-HNE (GCLC
Cys553, GCLM Cys35) [232]. 4-HNE also induces antioxidant genes
(e.g., TrxR1, heme oxygenase-1) through the induction of the Nrf2
promoter by modifying Cys288 of Keap1 [58,233]. Conversely, 4-
HNE inhibits the release of NF-κB by modifying Cys179 of IKK-β
[234]. Together, these examples emphasize that irreversible mod-
iﬁcation of Cys in signaling proteins is functionally important to
respond to electrophile exposures [229].
Selectivity of protein Cys to electrophilic modiﬁcation has been
demonstrated by comparisons of proteins modiﬁed by iodoacetyl
and maleimido reagents [235]. For instance, of 1255 distinct Cys-
containing peptides from isolated mitochondria, the electrophiles
overlapped only 35% in Cys adduction and had distinctly different
effects on cytotoxicity and apoptosis. Similarly in nuclear–cytosolic
fractions, there was only 14% peptidyl Cys overlap between the
electrophiles [236]. The targeted residues represented proteins
involved in a variety of central cellular pathways including Trx2,
heat shock proteins, permeability transition pore complex,
nuclear/cytosolic cytoskeleton, DNA replication/repair, protein
synthesis, and RNA processing [236].
As described above, the Cys proteome is part of an adaptive
interface of an organism with its environment, and covalent
modiﬁcations of the Cys proteome are useful to characterize
environmental exposures to pollutants, dietary metabolites, drug
metabolites, and endogenous toxicants [237]. In human serum
albumin, 66 adducts of Cys34 have been detected [238]. Similarly
in drug metabolism, quinone structures from metabolites of
acetaminophen (APAP), diclofenac, and related drugs have distinct
1,4-Michael addition reaction with thiols to form a covalently
modiﬁed Cys34 of albumin. The APAP metabolite N-acetyl-p-
benzoquinone imine (NAPQI) targets peptidyl Cys of essential
metabolic and regulatory proteins, including TrxR1, which is
covalently modiﬁed by NAPQI at residues Cys59 (GR-homologous
active residue) and Cys497 and Sec498 (vicinal thiol–selenol pair),
and associates these modiﬁcations with loss of TrxR activity in
APAP-overdose mouse liver [239]. Other modiﬁcations also occur,
such as GAPDH Cys149 modiﬁcation by NAPQI [240].
Integrated function of the Cys proteome
The proteome is the embodiment of the genome, serving to
translate the genetic and epigenetic systems into function and
interaction with the environment. The series of posttranslational
modiﬁcations of the translated proteome, collectively termed the
epiproteome [241], dramatically expands the structural variation
and range of reactivity beyond that found in the translated
proteome. Perhaps most importantly, bi- and multiphasic switches
of the Cys proteome provide organizational hubs to broadly
control and integrate complex biologic functions.
Although not fully elucidated, recent studies have begun to
deﬁne multiphasic switching by the Cys proteome through detec-
tion of proteins with S-nitrosylation, S-glutathionylation, persulﬁ-
dation, and sequential oxygenation [242]. Some Cys residues can
undergo multiple modiﬁcations, potentially providing pathway
switches to change biologic function. For instance, Cys374 of actin
can be nitrosylated as well as glutathionylated [107,109]. However,
comparison of sulfenylated Cys residues in 193 proteins with
previously identiﬁed targets of glutathionylation, disulﬁde forma-
tion, and S-nitrosylation shows minimal overlap [25]. These results
suggest that different Cys modiﬁcations are selectively targeted
toward different subsets of the Cys proteome rather than serving
as multidirectional switches. Expansion of this pioneering
research is needed to provide an understanding of the integrated
function of the Cys proteome.
At the same time, multiple omics platforms are being used to
translate basic science into medical applications [243]. Compar-
ison to genomics and transcriptomics illustrates current limita-
tions at the level of the Cys proteome. Unlike the genome and
epigenome, for which systematic methods provide nearly com-
prehensive coverage, only a few percent of the Cys in the
proteome are captured in the best mass spectrometry proteomics
analyses. In studies of gene expression–redox proteomic interac-
tions [244] common pathway responses were observed, but the
data were too sparse to allow direct correlation. On the other
hand, more targeted analysis of redox proteomic associations with
metabolomics in isolated mitochondria provided direct correla-
tions [24]. The data indicate that with improved coverage of the
proteome, integrated omics research will enable mechanistic
understanding at the level of systems biology, i.e., directly linking
changes in the Cys proteome with altered biologic function.
Perspective and future directions
A conceptual framework is emerging for elucidation of the Cys
proteome as a central omics layer within the continuum of
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interactive systems linking the genome and the exposome (Fig. 1).
Major gaps exist, however, in the hierarchy of interactions of Cys
proteome subnetworks, i.e., how do the various oxidation, nitro-
sylation, persulﬁdation, metalation, and alkylation subnetworks
synergize or antagonize one another? Sufﬁcient detailed under-
standing of individual Cys proteomics systems is available to
initiate the construction of more complex systems models using
a “bottom-up” approach. However, a limitation of a bottom-up
approach is that an atlas of Cys modiﬁcations is required to place
individual signaling elements within the context of others. This
highlights a need for systematic development of resources for
systems biology of the Cys proteome. With advances in mass
spectrometry-based methods, increased coverage of large seg-
ments of the Cys proteome is possible. But consortium efforts will
be needed to approach the coverage currently available for the
genome and transcriptome. Such resources could allow develop-
ment of quantitative models to test the functions of the various
Cys proteome subnetworks with existing physiologic, pharmaco-
logic, toxicologic, and genetic tools.
Such quantitative descriptions of Cys proteome pathways and
networks are essential to understand sites of vulnerability in
disease mechanisms and provide a foundation for a new genera-
tion of network-based redox therapeutics. Many manipulations of
the Cys proteome have been used in human research and some are
effective in clinical practice. For instance, global regulation of Trx1
and GSH systems occurs through the activation of the Nrf2 system,
a system targeted to prevent neurodegeneration [245], in cancer
prevention [246], in cardiovascular disease [247], and in other
disease processes [248].
Although optimism is appropriate concerning such applica-
tions, there is also need for recognition of the failures of free
radical-scavenging antioxidant trials [249,250] as manipulations of
the Cys proteome are pursued for health outcomes. The research
discussed in this review shows that the Cys proteome is a complex
network, apparently with an evolved function to support adapta-
tion to diet and environment. Therapeutic manipulations are, in
effect, environmental perturbations. Hence, outcomes of treat-
ments to modify the Cys proteome may suffer the same fate as the
antioxidant trials if network structures are not considered in the
study design.
Fortunately, the range of modiﬁcations for biological switching
of structure and reactivity is now well established. Methods are
available to quantify abundance and reactivity, to incorporate
reactions with electrophilic chemicals and binding to metal ions,
to elucidate the details of the switching systems, and to deﬁne
their compartmentalized functions. With these capabilities,
advanced integrative models, with links to imaging and other
omics platforms, will provide capabilities to recognize the ther-
apeutic potential available through targeting the cysteine
proteome.
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